image
Figure 6: Survival rates of mice with Ehrlich solid ascites carcinoma. U-133 was administered subcutaneously in dose of 100 mg/kg. Arrow indicates the days of compound administration (a) Representative photograph of tumor-bearing mouse of control group (b) and experimental group received U-133 (c) on 12th day post tumor inoculation.